Delivery Order SPE2DB22D1106-SPE2DB25FFCP8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,075.75 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and operates under firm fixed price terms. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a $6,621.75 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,055.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, just three days after the award date of July 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 44 mcg 10.6gm inhalers, valued at $1,257.22. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram containers. This is a firm fixed-price delivery order with a ceiling value of $1,501.78 and an ultimate completion date of August 11, 2025. The contract was competitively awarded without a set-aside designation, and performance will be executed at the contractor's location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 mcg in 12-gram units, valued at $1,789.77. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,301.76 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12 grams) on August 11, 2025, with completion due by August 12, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCP8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,301.76 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram units. This award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling Defense Department pharmaceutical procurement requirements through competitive awards, with this particular delivery order reflecting the company's role as a critical supplier of both brand-name and generic medications to federal medical supply chains supporting the Defense Health Agency and broader military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/11/25 |